Hospitalogy August 7, 2024
Blake Madden

GLP-1s are on track to be one of the most profitable drug classes of all time – and everyone wants in on the action.

With the growing conversation around obesity, there’s also a controversy bubbling under the surface ready to overflow.

No, I’m not talking about my terrible pasta making skills (how do you...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Biotechnology, Digital Health, Pharma / Biotech, Technology, Telehealth
Election Implications for Telehealth, Health Equity, AI and Life Sciences
Telehealth Advocates Praise DEA’s 3rd Extension of Telemedicine Flexibilities, but Call for Further Action
Trending in Telehealth: October 29 - November 11, 2024
How we can safeguard patients without restricting telehealth access
Sanford Health launches hub for virtual care

Share This Article